Additional Information

Emanuel applies a combination of high-throughput single cell assays, mathematical/computational modeling and biophysical measurements to improve the quantitative understanding of the evolving interactions between the immune system and tumor cells. Emanuel’s long-term goal is to help develop a quantitative model that can be used to predict the treatment combinations most likely to be successful for each cancer patient